Effects of the Antioxidant Sulforaphane on Hyperlocomotion and Prepulse Inhibition Deficits in Mice after Phencyclidine Administration

Sigma-1 Receptor Agonists as Therapeutic Drugs for Cognitive Impairment in Neuropsychiatric Diseases

(2012) Tomihisa Niitsu et al.   CURRENT PHARMACEUTICAL DESIGN

Pharmacological Targeting of the Transcription Factor Nrf2 at the Basal Ganglia Provides Disease Modifying Therapy for Experimental Parkinsonism

(2011) Agnieszka Jazwa et al.   ANTIOXIDANTS & REDOX SIGNALING

α7 Nicotinic Acetylcholine Receptor as a Potential Therapeutic Target for Schizophrenia

(2011) Masatomo Ishikawa et al.   CURRENT PHARMACEUTICAL DESIGN

Sulforaphane Enhances Protection and Repair of Gastric Mucosa Against Oxidative stress In Vitro, and Demonstrates Anti-inflammatory Effects on Helicobacter pyloriInfected Gastric Mucosae in Mice and Human Subjects

(2011) Akinori Yanaka   CURRENT PHARMACEUTICAL DESIGN

Glycine Transporter-1: A New Potential Therapeutic Target for Schizophrenia

(2011) Kenji Hashimoto et al.   CURRENT PHARMACEUTICAL DESIGN

Protective effects of the antioxidant sulforaphane on behavioral changes and neurotoxicity in mice after the administration of methamphetamine

(2011) Hongxian Chen et al.   PSYCHOPHARMACOLOGY

Antioxidant Therapeutics for Schizophrenia

(2010) Ravinder Reddy et al.   ANTIOXIDANTS & REDOX SIGNALING

The Role of Energy Metabolism Dysfunction and Oxidative Stress in Schizophrenia Revealed by Proteomics

(2010) Daniel Martins-de-Souza et al.   ANTIOXIDANTS & REDOX SIGNALING

Genetic Association Studies of Antioxidant Pathway Genes and Schizophrenia

(2010) Kodavali V. Chowdari et al.   ANTIOXIDANTS & REDOX SIGNALING

Magnetic Resonance Spectroscopy Study of the Antioxidant Defense System in Schizophrenia

(2010) Daisuke Matsuzawa et al.   ANTIOXIDANTS & REDOX SIGNALING

Antioxidants, Redox Signaling, and Pathophysiology in Schizophrenia: An Integrative View

(2010) Jeffrey K. Yao et al.   ANTIOXIDANTS & REDOX SIGNALING

Orally active glutamate carboxypeptidase II inhibitor 2-MPPA attenuates dizocilpine-induced prepulse inhibition deficits in mice

(2010) Yuto Takatsu et al.   BRAIN RESEARCH

Oxidative stress in schizophrenia: An integrated approach

(2010) Byron K.Y. Bitanihirwe et al.   NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS

Molecular Targets of Dietary Phenethyl Isothiocyanate and Sulforaphane for Cancer Chemoprevention

(2009) Ka Lung Cheung et al.   AAPS Journal

Co-Administration of a D-Amino Acid Oxidase Inhibitor Potentiates the Efficacy of D-Serine in Attenuating Prepulse Inhibition Deficits After Administration of Dizocilpine

(2009) Kenji Hashimoto et al.   BIOLOGICAL PSYCHIATRY

Dietary Sulforaphane-Rich Broccoli Sprouts Reduce Colonization and Attenuate Gastritis in Helicobacter pylori-Infected Mice and Humans

(2009) A. Yanaka et al.   Cancer Prevention Research

Effects of quetiapine on phencyclidine-induced cognitive deficits in mice: A possible role of α1-adrenoceptors

(2009) Yuko Tanibuchi et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

How High-Resolution Basal-State Functional Imaging Can Guide the Development of New Pharmacotherapies for Schizophrenia

(2009) I. Gaisler-Salomon et al.   SCHIZOPHRENIA BULLETIN

Targeting NRF2 signaling for cancer chemoprevention

(2009) Mi-Kyoung Kwak et al.   TOXICOLOGY AND APPLIED PHARMACOLOGY

Regarding “N-Acetyl Cysteine as a Glutathione Precursor for Schizophrenia—A Double-Blind, Randomized, Placebo-Controlled Trial”

(2008) Kenji Hashimoto   BIOLOGICAL PSYCHIATRY

Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of the antipsychotic drug perospirone: Role of serotonin 5-HT1A receptors

(2008) Hiroko Hagiwara et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Subchronic and chronic PCP treatment produces temporally distinct deficits in attentional set shifting and prepulse inhibition in rats

(2008) Alice Egerton et al.   PSYCHOPHARMACOLOGY

Phencyclidine-Induced Cognitive Deficits in Mice Are Improved by Subsequent Subchronic Administration of the Novel Selective α7 Nicotinic Receptor Agonist SSR180711

(2007) Kenji Hashimoto et al.   BIOLOGICAL PSYCHIATRY

Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of the glycine transporter-1 inhibitor NFPS and d-serine

(2007) Kenji Hashimoto et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY